RGA earned $736 million in third-quarter pre-tax adjusted operating income, or $8.49 per share after tax, while trailing-12-month adjusted operating ROE reached 19.1%. Total premiums excluding PRT grew 8.9% year-to-date, and the company returned $139 million to shareholders.
RGA · Reinsurance Group Of America Inc
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Up next
Latest documents
Reinsurance Group of America, Incorporated reported nine-month 2026 income before income taxes of $1,670 million, up $640 million, driven primarily by the Equitable Holdings transaction and higher variable investment income, partly offset by higher investment-related losses.
Reinsurance Group of America, Incorporated reported third-quarter net income of $456 million, or $6.92 per diluted share, versus $253 million and $3.81 per diluted share. It returned $139 million and declared a $0.98 dividend payable December 1, 2026.
Metrics snapshot
Useful current figures from the complete screener profile.
AI Brief
Q3 FY26 earnings call · Nov 6, 2026TL;DR. RGA reported sharply higher adjusted operating earnings, 19.1% trailing adjusted operating ROE, 25.0% premium growth, strong investment income, and $139 million of shareholder returns. Offsetting headwinds included weaker Asia Pacific traditional claims results, foreign-currency and tax pressure, an unfavorable EMEA assumption-review impact, expected normalization of alternative investment returns, and the medical excess business rolling off.
- + Adjusted operating income increased to $8.49 per diluted share from $4.66 in the prior-year quarter.
- + Trailing-twelve-month adjusted operating ROE excluding notable items was 19.1%.
- + Consolidated net premiums increased 25.0% to $5.4 billion from the prior-year quarter.
- + Investment income excluding spread-based businesses increased 17.5% from the prior-year quarter.
- + RGA completed four pension risk transfer transactions totaling over $800 million in combined premium.
- + RGA returned $139 million to shareholders in the quarter through $75 million of repurchases and $64 million of dividends.
- − Asia Pacific Traditional results excluding notable items decreased from the prior-year quarter due to less favorable claims experience.
- − The EMEA Traditional segment incurred a $31 million unfavorable impact from the annual actuarial assumption review.
- − Foreign currency fluctuations reduced net income by $0.11 per diluted share and adjusted operating income by $0.15 per diluted share.
- − The 24.1% adjusted operating tax rate exceeded the expected 22% to 23% range.
- − Management does not expect to repeat the quarter's high level of alternative investment returns in the fourth quarter.
- − The medical excess business is rolling off beginning in 2027 and will become smaller.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Annualized investment yield (ratio of net investment income to average invested assets at amorti | 5.26% | Three months ended September 30, 2026 filing | — |
| Annualized investment yield excluding VII (ratio of net investment income, excluding VII, to ave | 4.96% | Three months ended September 30, 2026 filing | — |
| Average invested assets at amortized cost | $50.38B | Three months ended September 30, 2026 filing | — |
| average yield earned on investments, excluding spread related business | 5.26% | three months ended September 30, 2026 filing | — |
|
|
|||
| Effect of actual variances from expected experience | -$23M | three months ended September 30, 2026 filing | — |
| net unfavorable assumptions updates | $31M | three months ended September 30, 2026 filing | — |
| Run-off of existing in force transactions | 1.8B | Three months ended September 30, 2026 filing | — |
| VII (included in net investment income) | $55M | Three months ended September 30, 2026 filing | — |
| Adjusted operating income before income taxes non-GAAP | $761M | the three months ended June 30, 2026 filing | — |
GAAP → non-GAAP reconciliationGAAP Income before income taxes $605M
+$181M Investment and derivative (gains) losses
-$26M Market risk benefits remeasurement (gains) losses
+$1M Change in fair value of funds withheld embedded derivatives
+$10M Funds withheld (gains) losses – investment income
+$0M Derivatives – interest credited
+$0M Investment income on unit-linked variable annuities
+$0M Interest credited on unit-linked variable annuities
+$0M Interest expense on uncertain tax positions
-$10M Other
= Adjusted operating income before income taxes $761M
|
|||
| Other operating expenses as a percentage of net premiums | 6.4% | Three months ended June 30, 2026 filing | — |
| Policy acquisition costs and other insurance expenses as a percentage of net premiums | 4.4% | Three months ended June 30, 2026 filing | — |
| Adjusted operating income non-GAAP | $1.05B | Six Months Ended June 30, 2026 | — |
GAAP → non-GAAP reconciliationGAAP Net income available to RGA shareholders 1.51B
+462M Capital (gains) losses, derivatives and other, net
-24M Change in fair value of embedded derivatives
-80M Tax expense on uncertain tax positions and other tax related items
+7M Net income attributable to noncontrolling interest
= Adjusted operating income 1.87B
|
|||
| Assumed life reinsurance in force | 4.34T | At June 30, 2026 | — |
| Assumed new business production | 280.3B | Six Months Ended June 30, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Insurance - Reinsurance — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
RGA
this stock
Reinsurance Group Of America Inc
|
$17.68B | +33.6% | +7.2% | 10.5 | 1.5% |
|
EG
Everest Group, Ltd.
|
$16.04B | +27.6% | +1.2% | 9.2 | 4.1% |
|
RNR
Renaissancere Holdings Ltd
|
$14.41B | +26.8% | +9.9% | 5.9 | 2.9% |
|
SPNT
SiriusPoint Ltd
|
$3.04B | +20.7% | +23.1% | 6.5 | 4.6% |
|
HG
Hamilton Insurance Group, Ltd.
|
$2.56B | +38.5% | +24.7% | — | 2.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Filed
- Nov 6, 2026
- This year
- 20
Reinsurance Group of America, Incorporated reported nine-month 2026 income before income taxes of $1,670 million, up $640 million, driven primarily by the Equitable Holdings transaction and higher variable investment income, partly offset by higher investment-related losses.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| RGA | +1.9% | +1.9% | +31.5% | +2.7% | +33.6% |
| SPY | -1.7% | -3.5% | -1.4% | -2.1% | +8.5% |
| vs SPY | +3.6% | +5.4% | +32.9% | +4.8% | +25.1% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.